DexCom Stock Forecast
DexCom stock upgraded to Buy Candidate.
(Updated on Apr 24, 2024)
The DexCom stock price gained 2.89% on the last trading day (Wednesday, 24th Apr 2024), rising from $134.00 to $137.87. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.55% from a day low at $132.48 to a day high of $138.50. The price has been going up and down for this period, and there has been a -1.75% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $445.04 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 18.04% during the next 3 months and, with a 90% probability hold a price between $151.22 and $170.42 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
DXCM Signals & Forecast
The DexCom stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $134.11 and $135.53. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 5.48%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for DexCom stock
DexCom finds support from accumulated volume at $133.72 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $6.03 (4.55%) between high and low. For the last week, the stock has had daily average volatility of 3.24%.
Our recommended stop-loss: $132.39 (-3.98%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 3 days ago.)
Trading Expectations (DXCM) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect DexCom to open at $136.28, and during the day (based on 14 day Average True Range), to move between $133.69 and $142.05, which gives a possible trading interval of +/-$4.18 (+/-3.03%) up or down from last closing price. If DexCom takes out the full calculated possible swing range there will be an estimated 6.06% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $139.93 (1.49%) than the support at $133.72 (3.01%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
DexCom will release earnings BMO on Thursday, April 25, 2024.The consensus among the analysts for the expected earnings (EPS) is $0.270. We will update the financials statements for DexCom, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 3.71% in the first trading day after earnings release.
Is DexCom stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for DexCom stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score: 1.208 Buy Candidate Upgraded
Predicted Opening Price for DexCom of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $136.28 ( 1.15%) | $137.87 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for DXCM
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 142.31 | 3.22 % | |
| R2 | 140.01 | 1.55 % | ||
| R1 | 138.58 | 0.517 % | ||
| Current price: | 137.87 | |||
| Support | S1 | 133.98 | -2.82 % | |
| S2 | 132.56 | -3.85 % | ||
| S3 | 130.26 | -5.52 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 140.45 | 1.87 % | |
| R2 | 140.10 | 1.62 % | ||
| R1 | 139.93 | 1.49 % | ||
| Current price | 137.87 | |||
| Support | S1 | 133.72 | -3.01% | |
| S2 | 120.47 | -12.62% | ||
| S3 | 116.26 | -15.67% |
FAQ
Click here for our free guide on how to buy DexCom Stock.
